Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress-Reference-Cited by-同舟云学术

Neoplastic and Stromal Cells Contribute to an Extracellular Matrix Gene Expression Profile Defining a Breast Cancer Subtype Likely to Progress

Published:2013-02-18 Issue:2 Volume:8 Page:e56761
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Triulzi Tiziana,Casalini Patrizia,Sandri Marco,Ratti Manuela,Carcangiu Maria L.,Colombo Mario P.,Balsari Andrea,Ménard Sylvie,Orlandi Rosaria,Tagliabue Elda

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Tumors as organs: complex tissues that interface with the entire organism;M Egeblad;Dev Cell,2010

2. Hallmarks of cancer: interactions with the tumor stroma;K Pietras;Exp Cell Res,2010

3. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis;C Chang;Trends Cell Biol,2001

4. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis;D Ilic;J Cell Biol,1998

5. Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells;CA Sherman-Baust;Cancer Cell,2003

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAF-induced physical constraints controlling T cell state and localization in solid tumours;Nature Reviews Cancer;2024-09-09

2. Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women;Frontiers in Genetics;2023-01-04

3. Immunotherapy and immunoengineering for breast cancer; a comprehensive insight into CAR-T cell therapy advancements, challenges and prospects;Cellular Oncology;2022-08-09

4. Gene Expression Signatures of the Tumor Microenvironment: Relation to Tumor Phenotypes and Progress in Breast Cancer;Biomarkers of the Tumor Microenvironment;2022

5. Impact of Immune Cell Heterogeneity on HER2+ Breast Cancer Prognosis and Response to Therapy;Cancers;2021-12-17